I recommend everyone to go A-Z.
With this article I try to explain how I did it, what I found and why I think it was a valuable exercise.
Link in bio or below.
#VLX $VLX Volex set new 'medium-term' targets, as the 1.2B$ revenue and 9-10% adj. EBIT margin goals set in 2022 will be achieved.
67% revenue growth and 2% margin growth leads to a double over 5 years. Of course only on the same multiples.
We have today confirmed our intention to move to the @LSEplc Main Market by 4 August 2026, subject to FCA approval.
We have also announced the launch of a ยฃ40 million share buyback programme.
Read the full details here: https://t.co/Fj7sjqNkCk
I recommend everyone to go A-Z.
With this article I try to explain how I did it, what I found and why I think it was a valuable exercise.
Link in bio or below.
I recommend everyone to go A-Z.
With this article I try to explain how I did it, what I found and why I think it was a valuable exercise.
Link in bio or below.
In case someone has any questions regarding my A-Z journey on AIM, about AIM itself, the process, ... let me know, I'll answer them in my wrap-up next week.
5x watchlist today. We also come across #VLX. Even the tickers I passed on might be interesting: turnaround case, an wine retailer with a big buyback program and UKโs leading bathroom retailer. Iโd say this is the best part of the whole series.
Link in bio or below.
@olliejmorgan https://t.co/AXd6IvLBow Yes, note says 'worth a look when industry recoveres', top-line seems to recover in FY26 but margins still low. Might be the bottom yes, thank you.
Today, a pharma distributor with over 50% market share in its home market, with ambitious growth plans and a good track record. #UPR
Link in bio or below.